Monica Pianella

Monica Pianella currently serves as Associate Director of Regulatory Affairs at Boyds since November 2023, following a tenure as Senior Regulatory Affairs Manager at Cell and Gene Therapy Catapult from January 2020 to October 2023. Monica's experience encompasses strategic planning, regulatory submissions, and project management for advanced therapies, alongside providing mentorship and guidance to regulatory team members. Previous roles include regulatory affairs positions focused on CMC documentation and project support at GSK, where Monica contributed to innovative formulations for T-cell therapies, and involvement with the MHRA British Pharmacopoeia in developing best practice documents for advanced therapies. Monica holds a Master of Science in Pharmaceutical Chemistry and Technology from Sapienza Università di Roma and has completed research at both the University of Rome "La Sapienza" and the University of Rhode Island.